Aarab Y, Flatres A, Garnier F, Capdevila M, Raynaud F, Lacampagne A, Chapeau D, Klouche K, Etienne P, Jaber S, Molinari N, Gamon L, Matecki S, Jung B  (2021). “Shear Wave Elastography, A New Tool for Diaphragmatic Qualitative Assessment. A Translational Study.  “. Am J Respir Crit Care Med. 2021 Oct 1;204(7):797-806. (IF=30,53). Critical Care Medicine (Q1) ; Respiratory System (Q1)).

Akodad M, Aldhaheri E, Marin G, Roubille F, Macia JC, Gandet T, Delseny D, Schmutz L, Lattuca B, Robert P, Dubard A, Robert G, Targosz F, Maupas E, Albat B, Cayla G, Leclercq F.  (2021). “Transcatheter aortic valve replacement performed with selective telemetry monitoring: A prospective study.  “ Int J Cardiol. 2021 May 1;330:158-163. (IF=4,04). Cardiac and Cardiovascular Systems (Q2).

Allimant C, Deshayes E, Kafrouni M, Santoro L, de Verbizier D, Fourcade M, Cassinotto C, Hermida M, Guillot C, Mariano-Goulart D, Guiu B. (2021). “ Hepatobiliary Scintigraphy and Glass ⁹⁰Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver.  “ Diagnostics (Basel). 2021 May 21;11(6):931 (IF=4,00). Medicine General and Internal (Q1).

Amedro P, Werner O, Abassi H, Boisson A, Souilla L, Guillaumont S, Calderon J, Requirand A, Vincenti M, Pommier V, Matecki S, De La Villeon G, Lavastre K, Lacampagne A, Picot MC, Beyler C, Delclaux C, Dulac Y, Guitarte A, Charron P, Denjoy-Urbain I, Probst V, Baruteau AE, Chevalier P, Di Filippo S, Thambo JB, Bonnet D, Pasquie JL (2021). ”Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods. . ” Health Qual Life Outcomes. 2021 Jul 28;19(1):187. (IF=3,10). Health Policy and Services (Q2).

Amedro P, Huguet H, Macioce V, Dorka R, Auer A, Guillaumont S, Auquier P, Abassi H, Picot MC  (2021). “Psychometric validation of the French self and proxy versions of the PedsQL™ 4.0 generic health-related quality of life questionnaire for 8-12 year-old children.  “. Health Qual Life Outcomes. 2021 Mar 4;19(1):75. (IF=3,10). Health Policy and Services (Q2).

Amedro P, Werner O, Abassi H, Boisson A, Souilla L, Guillaumont S, Calderon J, Matecki S, De La Villeon G, Requirand A,  Vincenti M, Pommier V, Lavastre K,  Lacampagne A. Picot MC, Beyler C, Delclaux C, Dulac Y, Guitarte A, Charron P, Denjoy-Urbain  I, Probst V, Elouen Baruteau A, Chevalier P, Di Filippo S, Thambo JB, Bonnet D, Pasquie  JL. (2021). Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods. ” Health and Quality of Life Outcomes BMC 2021 Jul 28;19(1):187. (IF=3,10). Health Policy and Services (Q2).

Angebault C, Panel M, Lacôte M, Rieusset J, Lacampagne A, Fauconnier J (2021). ”Metformin Reverses the Enhanced Myocardial SR/ER-Mitochondria Interaction and Impaired Complex I-Driven Respiration in Dystrophin-Deficient Mice.  ” Front Cell Dev Biol. 2021 Jan 25;8:609493. (IF=6,08). Cell Biology (Q2); Developmental Biology (Q1).

Audurier Y, Roubille C, Manna F, Zerkowski L, Faucanie M, Macioce V, Castet-Nicolas A, Jalabert A, Villiet M, Fesler P, Lohan-Descamps L, Breuker C. (2021). “Development and validation of a Score to Assess Risk of Medication Errors detected during medication reconciliation process at admission in Internal Medicine Unit: SCOREM study.  “ Int J Clin Pract. 2021 Feb;75(2):e13663. (IF=3,15). Medicine General and Internal (Q2) .

Banuls L, Vanoverschelde J, Garnier F, Amalric M, Jaber S , Charbit J, Chalard K , Mourad M, Benchabane N, Benomar R, Besnard N, Daubin D, BrunotV, Klouche K and Larcher R (2021).  “Interstitial Lung Disease Worsens Short-and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study“ J Clin Med , 2021, 10,1037 (IF=4,96). Medicine, General and Internal (Q1).

Berger M, Fesler P, Roubille C  (2021). ”Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases.  ”  Autoimmun Rev. 2021 Sep;20(9):102891. (IF=17,39). Immunology (Q1).

Berger M, Fesler P, Roubille C  (2021). “ Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases. “ .Autoimmun Rev. 2021 Sep;20(9):102891.(IF=17,39). Immunology (Q1).

Bergeret B, Secco LP, Pallure V, Daien C, Pers YM, Gottlieb J, Barete S, Girard C, Lipsker D, Bessis D; Study Group of Systemic Diseases in Dermatology (EMSED: Étude des Maladies Systémiques en Dermatologie).(2021). Palmoplantar lichen planus-like lupus erythematosus keratoderma: an underrecognized and distinctive cutaneous manifestation of systemic or subacute lupus erythematosus.  J Eur Acad Dermatol Venereol. 2021 Feb;35(2):e124-e126. (IF=9,23). Dermatology (Q1); Dermatology and Venereal Diseases ((Q1)

Bessière F, Gardey K, Bouzeman A, Duthoit G, Koutbi L, Labombarda F, Marquié C, Gourraud JB, Mondoly P, Sellal JM, Bordachar P, Hermida A, Anselme F, Asselin A, Audinet C, Bernard Y, Boveda S, Chevalier P, Clerici G, da Costa A, de Guillebon M, Defaye P, Eschalier R, Garcia R, Guenancia C, Guy-Moyat B, Henaine R, Irles D, Iserin L, Jourda F, Ladouceur M, Lagrange P, Laredo M, Mansourati J, Massoulié G, Mathiron A, Maury P, Nguyen C, Ninni S, Perier MC, Pierre B, Sacher F, Walton C, Winum P, Martins R, Pasquié JL, Thambo JB, Jouven X, Combes N, Di Filippo S, Marijon E, Waldmann V (2021). ”Impact of Pulmonary Valve Replacement on Ventricular Arrhythmias in Patients With Tetralogy of Fallot and Implantable Cardioverter-Defibrillator.  ” . JACC Clin Electrophysiol. 2021 Apr 21:S2405-500X(21)00220-6 (IF=6,12). Cardiology and Cardiovascular Medicine (Q1); Physiology (medical) (Q1)

Boheler KR, Meli AC, Yang HT. (2021). “Special issue on recent progress with hPSC-derived cardiovascular cells for organoids, engineered myocardium, drug discovery, disease models, and therapy.  “  Pflugers Arch. 2021 Jul;473(7):983-988.. (IF=4,46). Physiology (Q2).

Boisson A, De La Villeon G, Huguet M, Abassi H, Pasquie JL,^,Lavastre K, ^aMatecki S, Guillaumont S, Requirand A, Calderon J, Amedro P. (2021). “Physical activity and aerobic fitness in children with inherited cardiac diseases. “ Archives of Cardiovascular Diseases…, 2021 Nov;114(11):727-736. (IF=3,20). Cardiac ad Cardiovascular Systems (Q2).

Borges GSM, Lages EB, Sicard P, Ferreira LAM, Richard S.  (2021). “Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies.  “ Front Cardiovasc Med. 2021 Jun 30;8:690533.  (IF=5,85). Cardiac and Cardiovascular Systems (Q2).

Bresson D, Roubille F, Prieur C, Biere L, Ivanes F, Bouleti C, Dubreuil O, Rioufol G, Boutitie F, Sideris G, Elbaz M, Bochaton T, De Bourguignon C, El Jonhy N, Dufay N, Dhelens C, Croisille P, Prunier F, Angoulvant D, Ovize M, Maucort-Boulch D, Mewton N. (2021). “Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol – The COVERT-MI Study.  “ Cardiology. 2021 Feb 12:1-10. (IF=2,34). Cardiac and Cardiovascular Systems (Q4).

Breuker C, Guedj AM, Allan M, Coinus L, Molinari N, Chapet N, Roubille F, Le Quintrec M, Duhalde V, Jouglen J, Cestac P, Kinowski JM, Faure S, Faucanie M, Lohan L, Villiet M, Altwegg R, Sultan A.  (2021). “The COVID-19 Pandemic Led to a Small Increase in Changed Mentality Regarding Infection Risk without Any Change in Willingness to Be Vaccinated in Chronic Diseases Patients.  “ J Clin Med. 2021 Sep 1;10(17):3967.(IF=4,96). Medicine, General and Internal (Q1).

Bughin F, Jaussent I, Ayoub B, Aguilhon S, Chapet N, Soltani S, Mercier J, Dauvilliers Y, Roubille F. (2021). “Prognostic Impact of Sleep Patterns and Related-Drugs in Patients with Heart Failure.  “ J Clin Med. 2021 Nov 18;10(22):5387.  (IF=4,96). Medicine, General and Internal (Q1).

Bughin F, Bui G, Ayoub B, Blervaque L, Saey D, Avignon A, Brun JF, Molinari N, Pomies P, Mercier J, Gouzi F, Hayot M  (2021).”Impact of a Mobile Telerehabilitation Solution on Metabolic Health Outcomes and Rehabilitation Adherence in Patients With Obesity: Randomized Controlled Trial.”.JMIR Mhealth Uhealth. 2021 Dec 6;9(12):e28242. (IF=4,97). Health Care Sciences and Services (Q1) ; Medical Informatics (Q2).

Cazorla O, Barthélémy I, Su JB, Meli AC, Chetboul V, Scheuermann V, Gouni V, Anglerot C, Richard S, Blot S, Ghaleh B, Lacampagne A (2021). “Stabilizing Ryanodine Receptors Improves Left Ventricular Function in Juvenile Dogs With Duchenne Muscular Dystrophy. “ J Am Coll Cardiol. 2021 Dec 14;78(24):2439-2453. (IF=27,20). Cardiac ad Ca rdiovascular Systems  (Q1).

Chaigne S, Cardouat G, Louradour J, Vaillant F, Charron S, Sacher F, Ducret T, Guinamard R, Vigmond E, Hof T. (2021). ”Transient Receptor Potential Vanilloid 4 channel participates in mouse ventricular electrical activity.  ”Am J Physiol Heart Circ Physiol. 2021 Mar 1;320(3):H1156-H1169. (IF=5,12). Cardiac and Cardiovascular Systems (Q2); Physiology (Q1) ; Peripheral Vascular Diseases (Q2).

Chelly J, Plantefève G, Kamel T, Bruel C, Nseir S, Lai C, Cirillo G, Skripkina E, Ehrminger S, Berdaguer-Ferrari FD, Le Marec J, Paul M, Autret A, Deye N; ACICOVID-19 study group avec Larcher R comme collaborateur. (2021). “Incidence, clinical characteristics, and outcome after unexpected cardiac arrest among critically ill adults with COVID-19: insight from the multicenter prospective ACICOVID-19 registry. “ .Ann Intensive Care. 2021 Nov 13;11(1):155. (IF=10,32). Critical Care Medicine (Q1).

Chetboun M, Raverdy V, Labreuche J, Simonnet A, Wallet F, Caussy C, Antonelli M, Artigas A, Goma G, Meziani F, Helms J, Mylonakis E, Levy MM, Kalligeros M, Latronico N, Piva S, Cerf C, Neuville M, Klouche K, Larcher R, Tamion F, Occhiali E, Snacken M, Preiser JC, Kontar L, Riviere A, Silva S, Sarton B, Krouchi R, Dubar V, Palaiodimos L, Karamanis D, Perche J, L’her E, Busetto L, Dicker D, Lev S, Duhamel A, Jourdain M, Pattou F; (2021). “BMI and pneumonia outcomes in critically ill COVID-19 patients: an international multicenter study.  “LICORNE Lille Intensive Care COVID-19, Obesity Study Group”, the “COVID-19 Toulouse ICU Network”, the “Hasharon Hospital-Rabin Medical Center Covid-19, Obesity Study Group”, the “ID, ICU Covid-19 Study Group”, the “Rouen Covid-19, Obesity Study”, the “COVID-O-HCL Consortium”, the “MICU Lapeyronie”, the “Bronx COVID-19, Obesity Study Group”, the “MIR Amiens Covid19”, the “Strasbourg NHC”, the “Foch COVID-19 Study Group”. Obesity (Silver Spring) 2021 Sep;29(9):1477-1486. (IF=9,30). Endocrinology and Metabolism (Q2); Nutrition and Dietetics (Q2)

Coustal C, Du Thanh A, Roubille F, Assenat E, Maria ATJ  (2021). ”Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis. ”  Eur J Cancer. 2021 Jul 28;155:25-27. (IF=10,00). Oncology (Q1).

David H, Ughetto A, Gaudard P, Plawecki M, Paiyabhroma N, Zub E, Colson P, Richard S, Marchi N, Sicard P. (2021). “Experimental Myocardial Infarction Elicits Time-Dependent Patterns of Vascular Hypoxia in Peripheral Organs and in the Brain. “ Front Cardiovasc Med. 2021 Jan 27;7:615507. (IF=5,85). Cardiac and Cardiovascular Systems (Q2).

Decarriere G, Barnetche T, Combe B, Gaujoux-Viala C, Lukas C, Morel J, Daien C  (2021). “The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis.  “ Arthritis Care Res (Hoboken). 2021 Jun;73(6):873-884. (IF=5,18). Rheumatology (Q2).

Denormandie P, Simon T, Cayla G, Steg PG, Montalescot G, Durand-Zaleski I, Le Bras A, Le Breton H, Valy Y, Schiele F, Cuisset T, Vanzetto G, Levesque S, Goube P, Nallet O, Angoulvant D, Roubille F, Charles-Nelson A, Chatellier G, Danchin N, Puymirat E. (2021). “Compared Outcomes of ST-Elevation Myocardial Infarction Patients with Multivessel Disease Treated with Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Non-Culprit Lesions Treated Conservatively and of Those with Low Fractional Flow Reserve Managed Invasively: Insights from the FLOWER MI trial. “ Circ Cardiovasc Interv. 2021 Nov;14(11):e011314. (IF=7,51). Cardiac and Cardiovascular Systemms (Q1).

Doecke JD, Francois C, Fowler CJ, Stoops E, Bourgeat P, Rainey-Smith SR, Li QX, Masters CL, Martins RN, Villemagne VL, Collins SJ, Vanderstichele HM  (2021). “Core Alzheimer’s disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methods. “Alzheimers Res Ther. 2021 Apr 16;13(1):79. (IF=8,83). Clinical Neurology (Q1); Neurosciences (Q1).

Dubé MP, Legault MA, Lemaçon A, Lemieux Perreault LP, Fouodjio R, Waters DD, Kouz S, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GS, Asselin G, Provost S, Barhdadi A, Sun M, Cossette M, Blondeau L, Mongrain I, Dubois A, Rhainds D, Bouabdallaoui N, Samuel M, de Denus S, L’Allier PL, Guertin MC, Roubille F, Tardif JC. (2021). “Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.  “ Circ Genom Precis Med. 2021 Apr;14(2):e003183. (IF=7,46). Cardiac and Cardiovascular Systems (Q2) ; Genetics and Heredity (Q2).

Duflos C, Solecki K, Galinier M, Itier R, Roncalli J, Goger AL, Mandoraah B, Kalmanovich E, Huet F, Agullo A, Delseny D, Macia JC, Leclercq F, Mercier G, Roubille F. (2021). ”Conception and bicentric validation of the proSCANNED score, a simplified bedside prognostic score for Heart Failure patients.  ” Sci Rep. 2021 Mar 17;11(1):6179. (IF=5,00). Multidisciplinary Sciences  (Q1).

Duflos C, Labarre JP, Ologeanu R, Robin M, Cayla G, Galinier M, Georger F, Petroni T, Alarcon C, Aguilhon S, Delonca C, Battistella P, Agullo A, Leclercq F, Pasquie JL, Papinaud L, Mercier G, Ricci JE, Roubille F. (2021). “PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France.  “ ESC Heart Fail. 2021 Apr;8(2):1649-1655. (IF=3,61). Cardiac and Cardiovascular Systems  (Q1).

Dupuy AM, Badiou S, Montagnon V, Beaufils O, Sebbane M, Roubille F, Cristol JP (2021). “ Analytical assessment and performance of the 0/3h algorithm with novel high sensitivity cardiac troponin I. “Clin Chim Acta. 2021 Aug;519:111-117. (IF=6,31). Medical Laboratory Technology (Q2).

Dupuy AM, Pasquier G, Thiebaut L, Roubille F, Sebbane M, Cristol JP (2021). “Additive value of bioclinical risk scores to high sensitivity troponins-only strategy in acute coronary syndrome. “ .Clin Chim Acta. 2021 Oct 12;523:273-284.. (IF=6,31). Medical Laboratory Technology (Q2).

Faroux L, Lhermusier T, Vincent F, Nombela-Franco L, Tchétché D, Barbanti M, Abdel-Wahab M, Windecker S, Auffret V, Campanha-Borges DC, Fischer Q, Muñoz-Garcia E, Trillo-Nouche R, Jorgensen T, Serra V, Toggweiler S, Tarantini G, Saia F, Durand E, Donaint P, Gutierrez-Ibanes E, Wijeysundera HC, Veiga G, Patti G, D’Ascenzo F, Moreno R, Hengstenberg C, Chamandi C, Asmarats L, Hernandez-Antolin R, Gomez-Hospital JA, Cordoba-Soriano JG, Landes U, Jimenez-Diaz VA, Cruz-Gonzalez I, Nejjari M, Roubille F, Van Belle É, Armijo G, Siddiqui S, Costa G, Elsaify S, Pilgrim T, le Breton H, Urena M, Muñoz-Garcia AJ, Sondergaard L, Bach-Oller M, Fraccaro C, Eltchaninoff H, Metz D, Tamargo M, Fradejas-Sastre V, Rognoni A, Bruno F, Goliasch G, Santaló-Corcoy M, Jimenez-Mazuecos J, Webb JG, Muntané-Carol G, Paradis JM, Mangieri A, Ribeiro HB, Campelo-Parada F, Rodés-Cabau J.  (2021). “ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement.  “ J Am Coll Cardiol. 2021 May 4;77(17):2187-2199. (IF=27,20). Cardiac ad Ca rdiovascular Systems  (Q1).

Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. (2020). “Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial. “  Ann Rheum Dis. 2021 Mar;80(3):329-338. (IF=27,97). Rheumatolgy (Q1).

Fossier L, Panel M, Meli AC, Fauconnier J, Lacampagne A (2021). “Single Channel Biophysical Properties of the Left Ventricular Mitochondrial Calcium Uniporter Complex “ Biophysical Journal, 2021 25 Fev. 246a Poster abstract. (IF=3,70). Biophysics (Q1).

Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasquié JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E. (2021). ”Wearable cardioverter-defibrillator in patients with a transient risk of Sudden cardiac death: the WEARIT-France cohort study.  ” Europace. 2021 Jan 27;23(1):73-81. (IF=5,49). Cardiac and Cardiovascular Systems  (Q2).

Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, Assenat E, Tacher V, Robert C, Terroir-Cassou-Mounat M, Mariano-Goulart D, Amaddeo G, Palard X, Hollebecque A, Kafrouni M, Regnault H, Boudjema K, Grimaldi S, Fourcade M, Kobeiter H, Vibert E, Le Sourd S, Piron L, Sommacale D, Laffont S, Campillo-Gimenez B, Rolland Y; DOSISPHERE-01 Study Group.  (2021). “Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.”  Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29. (IF=202,73); Medicine, General and Internal (Q1). .

Gavotto A, Rivière B, Degravi L.  (2021). “Gastrointestinal bleeding and acute liver failure.  “ Gastroenterology. 2021 Dec;161(6):1811-1812.. (IF=33,88). Gastroenterology and Hepatology  (Q1).

Girerd N, Chapet N, Roubille C, Roncalli J, Salvat M, Mouquet F, Lamblin N, Gueffet JP, Damy T, Galinier M, Tartiere JM, Janssen C, Berthelot E, Aguilhon S, Escamilla R, Roubille F. (2021). “Vaccination for Respiratory Infections in Patients with Heart Failure. “  J  Clin Med. 2021 Sep 22;10(19):4311.  (IF=4,96). Medicine, General and Internal (Q1).

Goulabchand R, Roubille C, Montani D, Fesler P, Bourdin A, Malafaye N, Morel J, Arnaud E, Lattuca B, Barateau L, Guilpain P, Mura T  (2021); “Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database. “.J Clin Med. 2021 Oct 30;10(21):5115. (IF=4,96); Medicine, General and Internal (Q1). 

Grandperrin A, Schuster I, Rupp T, Izem O, Obert P, Nottin S  (2021). “Left ventricular dyssynchrony and post-systolic shortening in young bodybuilders using anabolic-androgenic steroids.  “  Am J Physiol Heart Circ Physiol. 2021 Sep 1;321(3):H509-H517. (IF= 5,12). Cardiac and Cardiovascular Systems (Q2); Physiology (Q1) ; Peripheral Vascular Diseases (Q2).

Gueguen N, Piarroux J, Sarzi E, Benkirane M, Manes G, Delettre C, Amedro P, Leboucq N, Koenig M, Meyer P, Meunier I, Reynier P, Lenaers G, Roubertie A.  (2021). “Optic neuropathy linked to ACAD9 pathogenic variants: a potentially riboflavin-responsive disorder?  “ Mitochondrion. 2021 Jul;59:169-174. (IF=4,53). Cell Biology (Q2) ; Genetics and Heredity (Q2).

Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, Jung B, Larcher R, Klouche K, Le Moing V.  (2021). “Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. “  Ann Rheum Dis. 2020 2021 Jan;80(1):e10. (IF=27,97). Rheumatolgy (Q1).

Hedon C, Lambert K, Chakouri N, Thireau J, Aimond F, Cassan C, Bideaux P, Richard S, Faucherre A, Le Guennec JY, Demion M.  (2020). .”New role of TRPM4 channel in the cardiac excitation-contraction coupling in response to physiological and pathological hypertrophy in mouse.  .” Prog Biophys Mol Biol.. 2021 Jan;159:105-117. (IF=4,80). Biochemistry and Molecular Biology (Q3) ;  Biophysics (Q3).

Homan T, Delanoë-Ayari H, Meli AC, Cazorla O, Gergely C, Mejat A, Chevalier P, Moreau A.(2021). “MorphoScript: a dedicated analysis to assess the morphology and contractile structures of cardiomyocytes derived from stem cells.  “ Bioinformatics. 2021 May 28;btab400. (IF=6,93). Biochemical Research Methods (Q1); Biotechnology and Applied Microbiology (Q1); Mathematical and Computational Biology (Q1; Computer Science and Interdisciplinary applications (Q1); Statistics and Probability (Q1).

Huet F , Dupuy AM, Duflos C, Azara Reis C, Kuster N , Aguilhon S, Cristol JP & Roubille F, (2021). “Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry.  “ Future Sci. OA 2021 Mar 29;7(5):FSO697.  (IF=2,61). Biotechnology (Q3) ; Medicine (Miscellaneous) (Q3).

Huet F, Delbaere Q, Aguilhon S, Dupasquier V, Delseny D, Gervasoni R, Macia JC, Leclercq F, Jammoul N, Kahlouche S, Soltani S, Cardon F, Dupuy AM, Cristol JP, Mariano-Goulart D, Akodad M, Nagot N, Roubille F. “Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol. “ Medicina (Kaunas). 2021 Sep 30;57(10):1047. (IF=2,95). Generzl Medicine (Q2).

Itier R, Guillaume M, Ricci JE, Roubille F, Delarche N, Picard F, Galinier M, Roncalli J.(2021). ”Non-alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues.  ” ESC Heart Fail. 2021 Apr;8(2):789-798. (IF=3,61). Cardiac and Cardiovascular Systems  (Q1).

Jaffuel D, Nogue E, Berdague P, Galinier M, Fournier P, Dupuis M, Georger F, Cadars MP, Ricci JE, Plouvier N, Picard F, Puel V, Mallet JP, Suehs CM, Molinari N, Bourdin A, Roubille F (2021). “Sacubitril-valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO-SAS study.  “ ESC Heart Fail. 2021 Aug;8(4):2513-2526. (IF=3,61). Cardiac and Cardiovascular Systems  (Q1).

Jelinkova S, Sleiman Y, Fojtík P, Aimond F, Finan A, Hugon G, Scheuermann V, Beckerová D, Cazorla O, Vincenti M, Amedro P, Richard S, Jaros J, Dvorak P, Lacampagne A, Carnac G, Rotrekl V, Meli AC. (2021). “Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.  Int J Mol Sci. 2021 May 10;22(9):5025.(IF=6,21). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary  (Q2).

Kalmanovich E, Battistella P, Rouviere P, Albat B, Frapier JM, Demaria R, Huet F, Agullo A, Mourad M, Colson P, Leclercq F, Gaudard P and RoubIille F.(2021). ” Idarucizumab (Praxbind®) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients ”Future Science OA, 2021 Feb 15;7(4):FSO689 (IF=2,61). Biotechnology (Q3) ; Medicine (Miscellaneous) (Q3).

Koutsoukis A, Delmas C, Roubille F, Bonello L, Schurtz G, Manzo-Silberman S, Puymirat E, Elbaz M, Bouisset F, Meunier PA, Huet F, Paganelli F, Laine M, Lemesle G, Lamblin N, Henry P, Tea V, Gallet R, Teiger E, Huguet R, Fard D, Lim P (2021). “Acute Coronary Syndromes in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care.  “ . CJC Open. 2021 Mar;3(3):311-317. (IF=1,90). Cardiac and Cardiovascular Systems (Q2).

Lambert K, Demion M, Lagacé JC, Hokayem M, Dass M, Virsolvy A, Jover B, Bourret A, Bisbal C. (2021) Grape polyphenols and exercise training have distinct molecular effects on cardiac hypertrophy in a model of obese insulin-resistant rats.  J Nutr Biochem. 2021 Jan;87:108522 (IF=6,12). Biochemistry and Molecular Biology (Q1) ; Nutrition and dietetics (Q1).

Lanot N, Adda J, Roubille F, Akodad M.  (2021). “Pheochromocytoma in a patient presenting with ventricular fibrillation and carotid dissection: a case report.  “ Eur Heart J Case Rep. 2021 Feb 4;5(2):ytab012.  (IS=0,78). Cardiology and Cardiovascular Medicine (Q4).

Larcher R, Platon L, Amalric M, Brunot V, Besnard N, Benomar R, Daubin D, Ceballos P, Rispail P, Lachaud L, Bourgeois N, Klouche K. (2021). “Emerging Invasive Fungal Infections in Critically Ill Patients: Incidence, Outcomes and Prognosis Factors, a Case-Control Study.  “ J Fungi (Basel). 2021 Apr 24;7(5):330. (IF= 5,72). Microbiology(Q1) ; Mycology (Q1).

Larcher R, Besnard N, Akouz A, Rabier E, Teule L, Vandercamere T, Zozor S, Amalric M, Benomar R, Brunot V, Corne P, Barbot O, Dupuy AM, Cristol JP, Klouche K.  (2021). “Admission High-Sensitive Cardiac Troponin T Level Increase Is Independently Associated with Higher Mortality in Critically Ill Patients with COVID-19: A Multicenter Study.  “ J Clin Med. 2021 Apr 13;10(8):1656. (IF=4,96). Medicine, General and Internal (Q1).

Larcher R, Kuster N, Bargnoux AS, Klouche K, Pieroni L, Cristol JP.  (2021). “Discrepant post-filter ionized calcium concentrations by 2 common gas analyzers in continuous renal replacement therapy using regional citrate anticoagulation: another piece of the puzzle.  “ Kidney Int. 2021 Jan;99(1):268-269.  (IF=19,00). Urology and Nephrology (Q1).

Laudette M, Sainte-Marie Y, Cousin G, Bergonnier D, Belhabib I, Brun S, Formoso K, Laib L, Tortosa F, Bergoglio C, Marcheix B, Borén J, Lairez O, Fauconnier J, Lucas A, Mialet-Perez J, Moro C, Lezoualc’h F. (2021). “ Cyclic AMP-binding protein Epac1 acts as a metabolic sensor to promote cardiomyocyte lipotoxicity. “ Cell Death Dis. 2021 Sep 1;12(9):824.  (IF=12,08). Cell Biology” (Q1).

Leclercq F, Odorico X, Marin G, Christophe Macia J, Delseny D, Agullo A, Pages L, Robert P, Lattuca B, Cayla G, Roubille F, Gaillard N, Arquizan C, Akodad M  (2021). “Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study. “ .Int J Cardiol Heart Vasc. 2021 Nov 20;37:100919. (IF=3,30). Cardiac and Cardiovascular Systems (Q2).

Lellouche N, Arrouasse R, Ternacle J, Gallet R, Hermida JS, Hamon D, Juliard JM, Pasquié JL, Dhanjal T, Teiger E, Le Corvoisier P.  (2021). ”Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry.  ” BMC Cardiovasc Disord. 2021 May 3;21(1):227 (IF=2,17). Cardiology and Cardiovascular Medicine (Q2)

Le Roy J, Azais B, Zarqane H, Vernhet Kovacsik H, Mura T, Lacampagne A, Amedro P.  (2021). «Selection of optimal cardiac phases for ECG-triggered coronary CT angiography in pediatrics.  Phys Med. 2021 Jan 15;81:155-161. (IF=3,12). Radiology Nuclear Medicine and Medical Imaging (Q2).

Le Tanno P, Folacci M, Revilloud J, Faivre L, Laurent G, Pinson L, Amedro P, Millat G, Janin A, Vivaudou M, Roux-Buisson N, Fauré J (2021). ”Characterization of Loss-Of-Function KCNJ2 Mutations in Atypical Andersen Tawil Syndrome. ” Front Genet. 2021 Nov 2021 Nov 25;12:773177. (IF=4,77). Genetics and Heredity (Q2).

Letertre S, Fesler P, Zerkowski L, Picot MC, Ribstein J, Guilpain P, Le Moing V, Mariano-Goulart D, Roubille C (2021) “Place of the ¹⁸F-FDG-PET/CT in the Diagnostic Workup in Patients with Classical Fever of Unknown Origin (FUO). “ J Clin Med. 2021 Aug 26;10(17):3831. . (IF=4,96). Medicine, General and Internal (Q1).

Lohan L, Galtier F, Manson T, Mura T, Castet-Nicolas A, Faure D, Chapet N, Leclercq F, Pasquié JL, Roubille F, Roubille C, Blain H, Guilpain P, Villiet M, Avignon A, Sultan A and Breuker C. (2021) “Compliance with Prescription Guidelines for Glucose-Lowering Therapies According to Renal Function: Real-Life Study in Inpatients of Internal Medicine“Medicina, 2021 Dec 17;57(12):1376 (IF=2,95). General Medicine (Q2).

Lotierzo M, Bruno R, Finan-Marchi A, Huet F, Kalmanovich E, Rodrigues G, Dupuy AM, Adda J, Piquemal D, Richard S, Cristol JP, Roubille F (2021). “ Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure? “ .Medicina (Kaunas). 2021 Sep 22;57(10):996. . (IF=2,95). Generzl Medicine (Q2).

Loubet P, Laureillard D, Martin A, Larcher R, Sotto A  (2021). “Why promoting a COVID-19 vaccine booster dose? “ .Anaesth Crit Care Pain Med. 2021 Dec;40(6):100967. (IF=7,02). Anaesthesiology (Q2) ; Critical Care Medicine ( Q3).

Lukas C, Redondin M, Pane I, Soubrier M, Houvenagel E, Sibilia J, Combe B, Morel J. (2021). “Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry.  “ Clin Exp Rheumatol. May-Jun 2021;39(3):501-507. (IF=4,86). Rheumatology (Q2)

Maïmoun L, Renard E, Huguet H, Lefebvre P, Boudousq V, Mahadea K, Picot MC, Doré R, Philibert P, Seneque M, Gaspari L, Courtet P, Sultan C, Sultan A, Laux D, Guillaume S, Mariano-Goulart D (2021). The quantitative ultrasound method for assessing low bone mass in women with anorexia nervosa.  Arch Osteoporos. 2021 Jan 14;16(1):13.  (IF=2,88). Endocrinology and Metabolism (Q4) ; Orthopedics (Q2).

Maïmoun L, Renard E, Humbert L, Aouinti S, Mura T, Boudousq V, Lefebvre P, Mahadea K, Philibert P, de Santa-Barbara P, Avignon A, Guillaume S, Sultan A, Nocca D, Mariano-Goulart D.  (2021). ” Modification of bone mineral density, bone geometry and volumetric BMD in young women with obesity.  ”  Bone. 2021 Sep;150:116005.. (IF=4,63).  Endocrinology and Metabolism (Q2).

Mandoorah B, Granier M, Pasquié JL. (2021).  “Vertebral osteophyte as an unexpected cause of atrial substrate modification in atrial fibrillation.  “ Europace. 2021 Jan 27;23(1):146. (IF=5,49). Cardiac and Cardiovascular Systems (Q2).

Mankia K, Siddle HJ, Kerschbaumer A, Alpizar Rodriguez D, Catrina AI, Cañete JD, Cope AP, Daien CI, Deane KD, El Gabalawy H, Finckh A, Holers VM, Koloumas M, Ometto F, Raza K, Zabalan C, van der Helm-van Mil A, van Schaardenburg D, Aletaha D, Emery P. (2021). “EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.  “ Ann Rheum Dis. 2021 Oct;80(10):1286-1298. (IF=27,97). Rheumatolgy (Q1).

Meghoufel ZF, Cherifi F, Boukra A, Terki F.(2021).”  Ab-initioinvestigation on the electronic and thermoelectric properties of new half-Heusler compounds KBiX(X= Ba and Sr). ”   J Phys Condens Matter. 2021 Jul 23;33(39).  (IF=2,74). Condensed Matter Physics (Q1); Materials Science (miscellaneous) (Q1)

Melhem N, Chajadine M, Gomez I, Howangyin KY, Bouvet M, Knosp C, Sun Y, Rouanet M, Laurans L, Cazorla O, Lemitre M, Vilar J, Mallat Z, Tedgui A, Ait-Oufella H, Hulot JS, Callebert J, Launay JM, Fauconnier J, Silvestre JS, and Taleb S. (2020) “ Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine.  “Circulation, 2021 Feb 9;143(6):566-580. (IF= 29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).

Meli AC, Fischmeister R. (2021). ”Scientists on the spot: Phosphodiesterases and heart failure.  ” Cardiovasc Res. 2021 Jan 21;117(2):e24-e25. (IF=13,08). Cardiac and Cardiovascular Systems (Q1).

Mercuzot C, Debien B, Riviere É, Martis N, Sanges S, Galland J, Kouchit Y, Fesler P, Roubille C  (2021). ‘Impact of a simulation-based training on the experience of the beginning of residency.  ‘Rev Med Interne. 2021 Nov;42(11):756-763.. (IF=0,88). Medicine General and Internal (Q4).

Mercuzot C, Letertre S, Daien C, Zerkowski L, Guilpain P, Terrier B, Fesler P, Roubille C.  (2021). “Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) – associated vasculitis. “  Autoimmun Rev. 2021 Jan;20(1):102708. (IF=17,39). Immunology (Q1).

Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, Ivanes F, Dubreuil O, Bière L, Hayek A, Derimay F, Akodad M, Alos B, Haider L, El Jonhy N, Daw R, De Bourguignon C, Dhelens C, Finet G, Bonnefoy-Cudraz E, Bidaux G, Boutitie F, Maucort-Boulch D, Croisille P, Rioufol G, Prunier F, Angoulvant D; (2021). “Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction. “COVERT-MI Study Investigators. Circulation. 2021 Sep 14;144(11):859-869. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).

Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, Khalil M, Féasson L, Cances C, Cottalorda J, Desguerre I, Cuisset JM, Sabouraud P, Lacampagne A, Chevassus H, Rivier F, Carnac G (2021). “Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients. “ Int J Mol Sci. 2021 Nov 30;22(23):12985. (IF=6,21). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary  (Q2).

Milési C, Requirand A, Douillard A, Baleine J, Nogué E, Matecki S, Amedro P, Pons-Odena M, Cambonie G  (2021). “Assessment of Peak Inspiratory Flow in Young Infants with Acute Viral Bronchiolitis: Physiological Basis for Initial Flow Setting in Patients Supported with High-Flow Nasal Cannula.  “ J Pediatr. 2021 Apr;231:239-245.e1. (IF=6,31). Pediatrics (Q1).

Moreau A, Reisqs JB, Delanoe‐Ayari H, Pierre M, Janin A, Deliniere A,  Bessière F, Meli AC, Charrabi A, Lafont E,  Valla C, Bauer D,  Morel E,  Gache V,  Millat G, Nissan X,  Faucherre A, Jopling C,  Richard S,  Mejat A,  Chevalier P. (2021). “Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy “ Clinical and Translational Medicine…2021 Mar;11(3):e319. (IF=8,55). Oncology (Q1); Medicine, Research and Experimental (Q1).

Mounier S, Gavotto A, Tenenbaum J, Meyer P, Fila M, Baleine J  (2021). “Hemolytic uremic syndrome related to Shiga-like toxin-producing Escherichia coli with encephalitis hiding a human herpesvirus-6 infection: a case report.  “  J Med Case Rep. 2021 May 25;15(1):300. (IF=0,88). Medical (miscellaneaous) (Q3).

Nassib J, Hireche K, Ozdemir BA, Alric P, Canaud L.  (2021). “Fate of the Dissected Thoraco-Abdominal Aorta Distal to TEVAR (Thoracic Endovascular Aortic Repair) for Complicated Acute and Subacute Type B Aortic Dissection.  “ J Endovasc Ther. 2021 Dec 27:15266028211065964.sous presse. (IF=3,09). Surgery (Q2) ; Peripheral Vascular Diseases (Q2).

Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI, Esbensen BA, Ferreira RJO, Fragoulis GE, Holmes P, McBain H, Metsios GS, Moe RH, Stamm TA, de Thurah A, Zabalan C, Carmona L, Bosworth A.  (2021). “2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis.  “ Ann Rheum Dis. 2021 Oct;80(10):1278-1285. (IF=27,97). Rheumatolgy (Q1).

O’Jeanson A, Larcher R, Le Souder C, Djebli N, Khier S  (2021). “Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation. “ .Eur J Drug Metab Pharmacokinet. 2021 Sep;46(5):695-705. (IF=2,57). Pharmacology and Pharmacy (Q3).

Palasset TL, Chaumais MC, Weatherald J, Savale L, Jaïs X, Price LC, Khouri C, Bulifon S, Seferian A, Jevnikar M, Boucly A, Manaud G, Pancic S, Chabanne C, Ahmad K, Volpato M, Favrolt N, Guillaumot A, Horeau-Langlard D, Prévot G, Fesler P, Bertoletti L, Reynaud-Gaubert M, Lamblin N, Launay D, Simonneau G, Sitbon O, Perros F, Humbert M, Montani D (2021). “Association between Leflunomide and Pulmonary Hypertension. “ Ann Am Thorac Soc. 2021 Aug;18(8):1306-1315. (IF=8,78). Respiratory System (Q1).

Pezel T, Audureau E, Mansourati J, Baudry G, Ben Driss A, Durup F, Fertin M, Godreuil C, Jeanneteau J, Kloeckner M, Koukoui F, Kesri-Tartière L, Laperche T, Roubille F, Cohen-Solal A, Damy T  (2021). “Diagnosis and Treatment of Iron Deficiency in Heart Failure: OFICSel study by the French Heart Failure Working Group. “  ESC Heart Fail. 2021 Apr;8(2):1509-1521. (IF=3,61). Cardiac and Cardiovascular Systems  (Q1).

Pommier V, Bredy C, Abassi H, Huguet H, Picot MC, Pierard S, Pasquet A, Iriart X, Thambo JB, Amedro P.  (2021). ”Reliability of echocardiographic parameters of the systemic right ventricle systolic function: A prospective multicentre study”  International Journal of Cardiology Congenital Heart Disease Volume 4, August 2021, 100139 (IF=2,24).Cardiac and Cardiovascular ystems (Q2).  

Porcher R, Desguerre I, Amthor H, Chabrol B, Audic F, Rivier F, Isapof A, Tiffreau V, Campana-Salort E, Leturcq F, Tuffery-Giraud S, Ben Yaou R, Annane D, Amédro P, Barnerias C, Bécane HM, Béhin A, Bonnet D, Bassez G, Cossée M, de La Villéon G, Delcourte C, Fayssoil A, Fontaine B, Godart F, Guillaumont S, Jaillette E, Laforêt P, Leonard-Louis S, Lofaso F, Mayer M, Morales RJ, Meune C, Orlikowski D, Ovaert C, Prigent H, Saadi M, Sochala M, Tard C, Vaksmann G, Walther-Louvier U, Eymard B, Stojkovic T, Ravaud P, Duboc D, Wahbi K. (2021). “Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy-analysis of registry data.  . “ Eur Heart J. 2021 May 21;42(20):1976-1984.. (IF=35,85). Cardiac ad Cardiovascular Systems (Q1).

Rioufol G, Dérimay F, Roubille F, Perret T, Motreff P, Angoulvant D, Cottin Y, Meunier L, Cetran L, Cayla G, Harbaoui B, Wiedemann JY, Van Belle É, Pouillot C, Noirclerc N, Morelle JF, Soto FX, Caussin C, Bertrand B, Lefèvre T, Dupouy P, Lesault PF, Albert F, Barthelemy O, Koning R, Leborgne L, Barnay P, Chapon P, Armero S, Lafont A, Piot C, Amaz C, Vaz B, Benyahya L, Varillon Y, Ovize M, Mewton N, Finet G; FUTURE Trial Investigators (2021). “Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.  “ . J Am Coll Cardiol. 2021 Nov 9;78(19):1875-1885. (IF=27,20). Cardiac and Cardiovascular Systems  (Q1).

Rouhana S, Virsolvy A, Fares N, Richard S, Thireau J. (2021). “Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning. “ Pharmaceuticals (Basel). 2021 Dec 25;15(1):31. (IF=5,21). Pharmacology and Pharmacy  (Q1) ; Chemistry, Medicinal (Q1).

Roubille C, Coffy A, Rincheval N, Dougados M, Flipo RM, Daurès JP, Combe B. (2021). “Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early Rheumatoid Arthritis.  “ Rheumatology (Oxford). 2021 Aug 2;60(8):3738-3746.. (IF=7,05). Rheumatology (Q1)

Roubille C, Coste J, Sellam J, Rat AC, Guillemin F, Roux CH  (2021). “ Association of Baseline Cardiovascular Diseases with 5-Year Knee and Hip Osteoarthritis Progression in Non-Obese Patients: Data from the KHOALA Cohort. “ .J Clin Med. 2021 Jul 29;10(15):3353. (IF=4,96). Medicine, General and Internal (Q1).

Roubille C, Ribstein J, Hurpin G, Fesler P, Fiat E, Roubille F. (2021)” Confidence vanished or impaired until distrust in the doctor-patient relationship because of COVID-19: Confidence vanished or impaired until distrust: “COVID” in relationship.  ”La Revue de médecine interne 2021 Jan;42(1):58-60.. (IF=0,88).  Medicine General and Internal (Q4).

Roubille F, Lamblin N.  (2021); “A New Requirement for Publication: Access to Effective Drugs for Ethical Reasons, The Example of Heart Failure.  “ ESC Heart Fail. 2021 Apr;8(2):799-801. (IF=3,61). Cardiac and Cardiovascular Systems (Q2). 

Rubenstein E, Larcher R, Altwegg R, Pers YM  (2021). ”Exceptional Paraspinal Localization of Myositis in a Patient With Crohn Disease Under Tumor Necrosis Factor α Inhibitor Treatment: A Case Report”. J Clin Rheumatol. 2021 Oct 1;27(7):e291-e292 (IF=3,90). Rheumatology (Q3).

Ryckebusch F, Peterschmitt M, Granier M, Sauvion N.(2021). “Alfalfa leaf curl virus is efficiently acquired by its aphid vector Aphis craccivora but inefficiently transmitted.  “ J Gen Virol. 2021 Feb;102(2). (IF= 5,14). Biotechnology and Applied Microbiology (Q2) ; Virology (Q2).

Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Grégoire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, Dubé MP, Provencher M, Orfanos A, Blondeau L, Kouz S, L’Allier PL, Ibrahim R, Bouabdallaoui N, Mitchell D, Guertin MC, Lelorier J (2021). “Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).  “ Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):486-495. (IF=7,06). Envinronmental and Occupationnal Health (Q1).

Sauer F, Jesel L, Marchandot B, Derimay F, Bochaton T, Amaz C, Roubille F, Cayla G, Rioufol G, Garcia-Dorado D, Claeys M, Angoulvant D, Bonnefoy-Cudraz E, Guérin P, Trinh A, Matsushita K, Ohlmann P, Jossan C, Mewton N, Ovize M, Morel O.  (2021). “Life-threatening arrhythmias in anterior ST-segment elevation myocardial infarction patients treated by percutaneous coronary intervention: adverse impact of morphine. “  Eur Heart J Acute Cardiovasc Care. 2021 May 25;10(4):427-436. (IF=4,77). Cardiac and Cardiovascular Systems (Q2).

Schaaf M, Croisille P, Py A, Roubille F, Biere L, Bochaton T, Perret T, Belle L, De Poli F, Hovasse T, Lairez O, Boussaha I, Rioufol G, Prunier F, Ovize M, Mewton N.  (2021). “Non-culprit artery myocardial infarction and complex coronary lesions in anterior ST-elevated myocardial infarction patients.  “ Cardiology. 2021;146(6):728-736. (IF=2,34). Cardiac and Cardiovascular Systems (Q4).

Sleiman Y, Lacampagne A, Meli AC  (2021). “Ryanopathies” and RyR2 dysfunctions: can we further decipher them using in vitro human disease models? ” .Cell Death Dis. 2021 Nov 1;12(11):1041. (IF=12,08). Cell Biology (Q1).

Sentenac P, Samarani G, Bideaux P, Sicard P, Bourdois B, Richard S, Colson PH, Eddahibi S.  (2021). “Pulmonary hypertension after pneumonectomy: a preclinical model in rats and human pulmonary endothelial cells. “  Eur J Cardiothorac Surg. 2021 Jan 4;59(1):147-154. (IF= 4,53). Cardiac and Cardiovascular Systems (Q2); Respiratory Sytems (Q2) ; Surgery (Q1).

Socchi F, Bigorre M, Normandin M, Captier G, Bessis D, Mondain M, Blanchet C, Akkari M, Amedro P, Gavotto A (2021). ” Hemangiol® in infantile haemangioma: A paediatric post-marketing surveillance drug study.  ”  Br J Clin Pharmacol. 2021 Apr;87(4):1970-1980 (IF=3,72). Pharmacy and Pharmacology (Q2).

Souidi M, Sleiman Y, Acimovic I, Pribyl J, Charrabi A, Baecker V, Scheuermann V, Pesl M, Jelinkova S, Skladal P, Dvorak P, Lacampagne A, Rotrekl V, Meli AC.  (2021). ”Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids.  ” Int J Mol Sci. 2021 Jan 11;22(2):E662. (IF=6,21). Biochemistry and Molecular Biology Q1) ; Chemistry, Multidisciplinary  (Q2). 

Svobodova B, Jelinkova S, Pesl M, Beckerová D, Lacampagne A, Meli AC, Rotrekl V (2021). “Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling.  “ Pflugers Arch. 2021 Jul;473(7):1099-1115. (IF=4,46). Physiology (Q2).

Valdeyron C, Soubrier M, Pereira B, Constantin A, Morel J, Gaudin P, Combe B, Gremeau AS, Dejou-Bouillet L, Pouly JL, Sapin V, Oris C, Brugnon F (2021). “Impact of disease activity and treatments on ovarian reserve in patients with rheumatoid arthritis in the ESPOIR cohort.  “ Rheumatology (Oxford). 2021 Apr 6;60(4):1863-1870. (IF=7,05). Rheumatology (Q1) 

Vincenti M, Farah C, Amedro P, Scheuermann V, Lacampagne A, Cazorla O. (2021). “Early Myocardial Dysfunction and Benefits of Cardiac Treatment in Young X-Linked Duchenne Muscular Dystrophy Mice.  “ Cardiovasc Drugs Ther. 2021 Jun 17. Sous presse. (IF=3,95). Cardiac and Cardiovascular Systems (Q2) : Pharmacology and Pharmacy (Q1).

Werner O, Bredy C, Lavastre K, Guillaumont S, De La Villeon G, Vincenti M, Gerl C, Dulac Y, Souletie N, Acar P, Pages L, Picot MC, Bourrel G, Oude Engberink A, Million E, Abassi H, Amedro P. (2021).  ” Impact of a transition education program on health-related quality of life in pediatric patients with congenital heart disease: study design for a randomised controlled trial.  ” Health Qual Life Outcomes. 2021 Jan 19;19(1):23. (IF=3,10). Health Policy and Services (Q2).

Xu T, Yehya M,  Singh A,  Gil T,  Bideaux P,  Thireau J,  Lacampagne A,  Charlot B, Todri-Sanial A ;(2021). “Dedicated Wearable Sensitive Strain Sensor, based on Carbon Nanotubes, for Monitoring the Rat Respiration Rate “ Eng. Proc. 2021, 3, , sous presse. (IF= en attente).

Abassi H, Bajolle F, Werner O, Auer A, Marquina A, Mura T, Lavastre K, Guillaumont S, Manna F, Auquier P, Bonnet D, Amedro P.  (2020).. “ Health-related quality of life correlates with time in therapeutic range in children on anticoagulants with International Normalised Ratio self-monitoring. ” Arch Cardiovasc Dis. 2020 Nov 12;18(1):366. (IF=2,34). Cardiac ad Cardiovascular Systems (Q2). 

Abassi H, Huguet H, Picot MC, Vincenti M, Guillaumont S, Auer A, Werner O, De La Villeon G, Lavastre K, Gavotto A, Auquier P, Amedro P.  (2020). “Health-related quality of life in children with congenital heart disease aged 5 to 7 years: a multicentre controlled cross-sectional study.  “ Health Qual Life Outcomes. 2020 Nov 12;18(1):366.  (IF=3,19). Health Policy and Services (Q2).

Akodad M, Delmas C, Bonello L, Duflos C, Roubille F.  (2020). “Intra-aortic balloon pump: is the technique really outdated?  “ ESC Heart Fail. 202020 Jun;7(3):1025-1030.. (IF= 4,41). Cardiac ad Cardiovascular Systems (Q2).

Akodad M, Sicard P, Fauconnier J, Roubille F  (2020). ”Colchicine and myocardial infarction: A review. ”  Arch Cardiovasc Dis. 2020 Oct;113(10):652-659. (IF=2,34). Cardiac ad Cardiovascular Systems (Q2)

Akodad M, Roubille F, Marin G, Lattuca B, Macia JC, Delseny D, Gandet T, Robert P, Schmutz L, Piot C, Maupas E, Robert G, Targosz F, Albat B, Cayla G, Leclercq F.  (2020). Myocardial Injury After Balloon Predilatation Versus Direct Transcatheter Aortic Valve Replacement: Insights From the DIRECTAVI Trial.  J Am Heart Assoc. 2020 Dec 10:e018405. (IF=5,50). Cardiac and Cardiovascular Systems  (Q1).

Alunno A, Nikiphorou E, Philippou E, Daien C, Wiek D, Kouloumas M, Cutolo M  (2020). «Nutrition in RMDs: is it really food for thought? Focus on rheumatoid arthritis.  BMC Rheumatol. 2020 Mar 10;4:10. (IF=1,47). Rheumatology (Q3).

Amalric M, Larcher R, Brunot V, Garnier F, De Jong A, Moulaire Rigollet V, Corne P, Klouche K, Jung B.  (2020). “Impact of Videolaryngoscopy Expertise on First-Attempt Intubation Success in Critically Ill Patients. “  Crit Care Med. 2020 Oct;48(10):e889-e896. (IF= 7,60). Critical Care Medicine (Q1).

Amedro P, Gavotto A, Abassi H, Picot MC, Matecki S, Malekzadeh-Milani S, Levy M, Ladouceur M, Ovaert C, Aldebert P, Thambo JB, Fraisse A, Humbert M, Cohen S, Baruteau AE, Karsenty C, Bonnet D, Hascoet S and on behalf of the SV-INHIBITION study investigators. (2020). “Efficacy of phosphodiesterase type 5 inhibitors in univentricular congenital heart disease: the SV-INHIBITION study design  “ESC Heart Fail 2020 Apr;7(2):747-756. (IF= 4,41). Cardiac and Cardiovascular  systems (Q2).

Audurier Y, Chapet N, Renaudin P, Bons C, Mathieu B, Theret S, de Barry G, Jalabert A, Breuker C, Leclercq F, Pasquie JL, Agullo A, Roubille F, Castet-Nicolas A  (2020). ”Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients?  ” Int J Clin Pract. 2020 Sep;74(9):e13531. (IF=2,50).  Medicine General and Internal  (Q2) .

Baudot M, Torre E, Bidaud I, Louradour J, Torrente AG, Fossier L, Talssi L, Nargeot J, Barrère-Lemaire S, Mesirca P, Mangoni ME  (2020). «Concomitant genetic ablation of L-type Ca_v1.3 (α_1D) and T-type Ca_v3.1 (α_1G) Ca²⁺ channels disrupts heart automaticity.  . Sci Rep. 2020 Nov 3;10(1):18906.  (IF=4,38). Multidisciplinary Sciences (Q1).

Bonello L, Delmas C, Gaubert M, Schurtz G, Ouattara A, Roubille F  (2020). ”Trials of mechanical circulatory support with percutaneous axial flow pumps in cardiogenic shock complicating acute myocardial infarction: Mission impossible?  ” . Arch Cardiovasc Dis. Jun-Jul 2020;113(6-7):448-460. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).

Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, Berry  C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GGS, Blondeau L, Orfanos A, Ibrahim R, Grégoire JC, Dube´MP, Samuel M, Morel O, Lim P, Bertrand OF, Kouz S, Guertin MC, L’Allier PL, and Roubille F. (2020). “Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).  “European Heart Journal (2020 Nov 7;41(42):4092-4099. (IF=29,98) Cardiac and Cardiovascular Systems (Q1)

Boulghobra D, Grillet PE, Mickaël L, Mathieu T, Fauconnier J, Fança-Berthon P, Reboul C, Cazorla O  (2020).“ Sinapine, but not sinapic acid, counteracts mitochondrial oxidative stress in cardiomyocytes. “- Redox Biology, Volume 34, July 2020, 101554 IF=11,80). Biochemistry and Molecular Biology (Q1).

Bughin F, Desplan M, Mestejanot C, Picot MC, Roubille F, Jaffuel D, Mercier J, Jaussent I, Dauvilliers Y.  (2020). “Effects of an individualized exercise training program on severity markers of obstructive sleep apnea syndrome: a randomised controlled trial.  “ Sleep Med. 2020 Feb 18;70:33-42.  (IF=3,49). Clinical Neurology (Q2).

Calderon J, Wypij D, Rofeberg V, Stopp C, Roseman A, Albers D, Newburger JW, Bellinger DC. (2020). “Randomized Controlled Trial of Working Memory Intervention in Congenital Heart Disease.  “ J Pediatr. 2020 Dec;227:191-198.e3. (IF=4,41). Domaine de Recherche: ” Pediatrics” (10/128, Q1).

Catteau M, Gouzi F, Blervaque L, Passerieux E, Blaquière M, Ayoub B, Bughin F, Mercier J, Hayot M, Pomiès P  (2020). ”Effects of a human microenvironment on the differentiation of human myoblasts.  ” Biochem Biophys Res Commun. 2020 May 14;525(4):968-973. (IF=3,57).  Biochemistry and Molecular Biology (Q3); Biophysics (Q2).

Cautela J, Tartiere JM, Cohen-Solal A, Bellemain-Appaix A, Theron A, Tibi T, Januzzi JL Jr, Roubille F, Girerd N.  (2020). ”Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients.  ”Eur J Heart Fail. 2020 Aug;22(8):1357-1365. (IF=15,53). Cardiac and Cardiovascular Systems (Q2).

Chadet S, Ternant D, Roubille F, Bejan-Angoulvant T, Prunier F, Mewton N, Paintaud G, Ovize M, Dupuy AM, Angoulvant D, Ivanes F.  (2020). “Kinetic modelling of myocardial necrosis biomarkers offers an easier, reliable and more acceptable assessment of infarct size. “ Sci Rep. 2020 Aug 12;10(1):13597. (IF=4,38). Multidisciplinary Sciences (Q1).

Chakouri N, Farah C, Matecki S, Amedro P, Vincenti M, Saumet L, Vergely L, Sirvent N, Lacampagne A, Cazorla O. (2020). “Screening for in-vivo regional contractile defaults to predict the delayed Doxorubicin Cardiotoxicity in Juvenile Rat.  “ Theranostics. 2020 Jul 9;10(18):8130-8142. (IF=11,56). Medicine, Research and Experimental (Q1).

Cinotti R, Besnard N, Desmedi L, Floch R, Perrot P, Bekara F, Klouche K, Larcher R, Mahé PJ, Frasca D, Asehnoune K, Jung B, Roquilly A. (2020). “Feasibility and impact of the implementation of a clinical scale-based sedation-analgesia protocol in severe burn patients undergoing mechanical ventilation. A before-after bi-center study“  Burns 2020 Sep;46(6):1310-1317. (IF= 2,74). Critical Care Medicine (Q3) ; Dermatology (Q2) ; Surgery (Q2).

Claeys MJ, Roubille F, Casella G, Zukermann R, Nikolaou N, De Luca L, Gierlotkaa M, Iakobishvili Z, Thiele H, Koutouzis M, Sionis A, Monteiro S, Beauloye C, Held C, Tint D, Zakke I, Serpytis P, Babic Z, Belohlavev J, Magdy A, Sivagowry Rasalingam M, Daly K, Arroyo D, Vavlukis M, Radovanovic N, Trendafilova E, Marandi T, Hassenger C, Lettino M, Price S, Bonnefoy E. (2020). “Organization of intensive cardiac care units in Europe: Results of a multinational survey. Eur Heart J Acute Cardiovasc Care. 2020 Dec;9(8):993-1001.  (IF=4,70).. Cardiac ad Cardiovascular Systems (Q2).

Claustre J, Larcher R, Jouve T, Truche AS, Nseir S, Cadiet J, Zerbib Y, Lautrette A, Constantin JM, Charles PE, Daubin C, Coudroy R, Dellamonica J, Argaud L, Phelouzat P, Contou D, Pocquet J, Voiriot G, Navellou JC, Lavagne P, Durand M, Cornet M, Schwebel C, Terzi N.  (2020). “Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy. “ Ann Intensive Care. 2020 Jun 8;10(1):74. (IF=6,92). Critical Care Medicine (Q1).

Couderc M, Pereira B, Schaeverbeke T, Thomas T, Chapurlat R, Gaudin P, Morel J, Dougados M, Soubrier M. (2020). “GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis.  “ BMJ Open. 2020 Nov 20;10(11):e038715.  (IF=2,69). Medicine General and Internal (Q2).

Dadouch M , Ladner Y , Bich C , Larroque M , Larroque C , Morel J , Bonnet PA , Perrin C. (2020). “An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis. “ Analyst. 2020 Mar 7;145(5):1759-1767. (IF=4,62). Chemistry, Analytical (Q1).

Dahiya, A. S., Gil, T., Thireau, J., Azemard, N., Lacampagne, A., Charlot, B., Todri‐Sanial (2020). “1D Nanomaterial‐Based Highly Stretchable Strain Sensors for Human Movement Monitoring and Human–Robotic Interactive Systems. “ Adv. Electron. Mater. 2020, vol 6 issue 10 (IF=7,29). Nanoscience and Nanotechnology (Q2) ; Materials Science Multidisciplinary (Q1) ; Physics Applied (Q1).

Dahiya AS, Gil T, Azemard N, Thireau J, Lacampagne A, Todri-Sanial A, Chariot B. (2020)- “Stretchable Strain Sensors for Human Movement Monitoring“2020 Symposium on Design, Test, Integration & Packaging of MEMS and MOEMS (DTIP), Lyon, France, 2020, pp. 1-4,

Dahiya A-S, Thireau J, Boudaden J, Lal S, Gulzar U, Zhang Y, Gil T, Azemard N, Ramm P, Kiessling T, O’Murchu C, Sebelius F, Tilly J, Glynn C, Geary S, O’Dwyer C, Razeeb K-M, Lacampagne A, Charlot B, and Todri-Sanial A. (2020). “Energy Autonomous Wearable Sensors for Smart Healthcare: A Review“ Journal of The Electrochemical Society, 2020 167 037516 (IF=4,32). Electrochemistry(Q2) ; Materials Science, Coating and Films (Q1).

Danchin N, Popovic B, Puymirat E, Goldstein P, Belle L, Cayla G, Roubille F, Lemesle G, Ferrières J, Schiele F, Simon T; FAST-MI Investigators. (2020). “Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme. “ Eur Heart J. 2020, 41 (7), 858-866  (IF=29,98). Cardiac ad Cardiovascular Systems (Q1).

Delmas C, Aissaoui N, Meneveau N, Bouvaist H, Rousseau H, Puymirat E, Sapoval M, Flecher E, Meyer G, Sanchez O, Del Giudice C, Roubille F, Bonello L.  (2020). “Reperfusion therapies in pulmonary embolism-state of the art and expert opinion: A position paper from the “Unité de Soins Intensifs de Cardiologie” group of the French Society of Cardiology.  “Arch Cardiovasc Dis. 2020 Nov;113(11):749-759. (IF=2,34). Cardiac ad Cardiovascular Systems (Q2).

Dupuy AM, Bargnoux AS, Larcher R, Merindol A, Masetto T, Badiou S, Cristol JP. (2020). “Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin.  “Diagnostics (Basel). 2020 Jul 7;10(7):E461.(IF=3,71). Medicine General and Internal (Q1).

Dupuy AM, Bargnoux AS, Roubille F, Cristol JP. (2020). “Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title “Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome”. “  Clin Chem Lab Med. 2020 Aug 3;59(4):e125-e127. (IF=3,69). Medical Laboratory Technology (Q1).

Dridi H, Yehya M, Barsotti R, Reiken S, Angebault C, Jung B, Jaber S, Marks AR, Lacampagne A, Matecki S. (2020). “Mitochondrial oxidative stress induces leaky ryanodine receptor during mechanical ventilation. “ Free Radic Biol Med. 2020 Jan;146:383-391 (IF=7,38). Biochemistry and Molecular  Biology (Q1) ; Endocrinology and Metabolism (Q1).

Dridi H, Liu X, Yuan Q, Reiken S, Yehya M, Sittenfeld LR, Apostolou P, Buron J, Sicard P, Matecki S, Thireau J, Menuet C, Lacampagne A, Marks AR  (2020). “Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington’s disease.  “  JCI Insight. 2020 Oct 2;5(19):140614. (IF=8,31). Medicine, Research and Experimental (Q1) .

Dridi H, Jung B, Yehya M, Daurat A, Reiken S, Moreau J, Marks AR, Matecki S, Lacampagne A, Jaber S.  (2020). “Late Ventilator-Induced Diaphragmatic Dysfunction After Extubation.  “Crit Care Med. 2020 Dec;48(12):e1300-e1305.  (IF=7,60). Critical Care Medicine (Q1).

Duflos C, Roubille C, Roubille F  (2020). “By half decrease of cardiovascular mortality in a Western country between 2000 and 2015: A contrasted picture advocating for a better management of comorbidities. “  Int J Cardiol. 2020 Nov 1;318:145-146. (IF=4,16). Critical Care Medicine (Q3).

Dupuy AM, Bargnoux AS, Roubille F, Cristol JP . (2020). “Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title “Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome”. “  Clin Chem Lab Med. 2020 Aug 1sous presse. (IF=3,69). Medical Laboratory Technology (Q1).

Ebstein E, Forien M, Norkuviene E, Richette P, Mouterde G, Daien C, Ea HK, Brière C, Lioté F, Petraitis M, Bardin T, Ora J, Dieudé P, Ottaviani S. (2020). «UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis. Joint Bone Spine. 2020 Dec;87(6):647-651. (IF=4,93). Rheumatology (Q2).

Eiden C, Pinzani V, Laureau M, Chapet N, Beringer J, Roubille F, Sebbane M, Peyrière H.  (2020). ”Clomiphene misuse and risk of severe cardiovascular events.  ” Eur J Clin Pharmacol. 2020 Jun;76(6):901-902. (IF=2,95). Pharmacology and Pharmacy ( Q2).

Elayi CS, Erath-Honold JW, Jabbari R, Roubille F, Silvain J, Barra S, Providencia R, Njein M, Narayanan K, Deharo JC, Defaye P, Boveda S, Leclercq C, Marijon E. (2020). ”Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease . ” Europace 2020 Oct 1;22(10):1600. (IF=5,21). Cardiac and Cardiovascular Systems (Q1).

Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, Mékinian A, Vittecoq O, Berthelot JM, Dernis E, Le Guern V, Dieudé P, Larroche C, Richez C, Martin T, Zarnitsky C, Blaison G, Kieffer P, Maurier F, Dellal A, Rist S, Andres E, Contis A, Chatelus E, Sordet C, Sibilia J, Arnold C, Tawk MY, Aberkane O, Holterbach L, Cacoub P, Saraux A, Mariette X, Meyer N, Gottenberg JE. (2020). “Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial. “  Ann Rheum Dis. 2020 Nov 18sous presse. (IF=19,10). Rheumatolgy (Q1).

Flattres A, Aarab Y, Nougaret S, Garnier F, Larcher R, Amalric M, Klouche K, Etienne P, Subra G, Jaber S, Molinari N, Matecki S, Jung B. (2020). “Real-time shear wave ultrasound elastography: a new tool for the evaluation of diaphragm and limb muscle stiffness in critically ill patients. “ Crit Care. 2020 Feb 3;24(1):34.(IF=9,10). Cardiac and Cardiovascular Systems (Q1).

Galinier M, Roubille F, Berdague P, Brierre G, Cantie P, Dary P, Ferradou JM, Fondard O, Labarre JP, Mansourati J, Picard F, Ricci JE, Salvat M, Tartière L, Ruidavets JB, Bongard V, Delval C, Lancman G, Pasche H, Ramirez-Gil JF, Pathak A;  (2020). “Telemonitoring versus standard of care in heart failure: a randomised multicentre trial.  “ OSICAT Investigators. Eur J Heart Fail. 2020 Jun;22(6):985-994. (IF=15,53). Cardiac and Cardiovascular Systems (Q1).

Garnier F, Daubin D, Larcher R, Bargnoux AS, Platon L, Brunot V, Aarab Y, Besnard N, Dupuy AM, Jung B, Cristol JP, Klouche K. (2020). “Reversibility of Acute Kidney Injury in Medical ICU Patients: Predictability Performance of Urinary Tissue Inhibitor of Metalloproteinase-2 x Insulin-Like Growth Factor-Binding Protein 7 and Renal Resistive Index. “Crit Care Med. 2020 Apr;48(4):e277-e284.. (IF=7,60). Critical Care Medicine (Q1).

Gavotto A, Huguet H, Picot MC, Guillaumont S, Matecki S, Amedro P. (2020). “The VE/VCO₂ slope: a useful tool to evaluate the physiological status of children with congenital heart disease.  “ J Appl Physiol (1985). 2020 Nov 1;129(5):1102-1110. (IF=3,53). Critical Care Medicine (Q1).

Gavotto A, Gauthier A, Werner O  (2020). “Cardiac abnormality in a prechemotherapy assessment for leukaemia in a 14-year-old girl.  “ Heart. 2020 Sep;106(18):1406-1450. (IF=5,99). Cardiac ad Cardiovascular Systems (Q1)

Gavotto A, Werner O, Amedro P. (2020). “Late infective endocarditis after transcatheter tricuspid valve-in-valve implantation: A pediatric case report. “Arch Pediatr.  Feb;27(2):107-109.  (IF=0,59). Pediatrics (Q4).

Gavotto A , Thomas F, Werner O, Moreau J, Amedro P  (2020). ” Use of treprostinil in pediatric pulmonary hypertension: case reports and review of the literature ” . J Cardiovasc Pharmacol 2020 Jul;76(1):23-31. (IF=2,46). Cardiac and Cardiovascular Systems (Q3); Pharmacology and Pharmacy (Q3).

Gavotto A, Vandenberghe D, Abassi H, Huguet H, Macioce V, Picot MC, Guillaumont S, Matecki S, Amedro P.  (2020). “Oxygen uptake efficiency slope: a reliable surrogate parameter for exercise capacity in healthy and cardiac children? “ Arch Dis Child.  2020 Dec;105(12):1167-1174. (IF=3,79). Pediatrics (Q1).

Gerges C, Gerges M, Friewald R, Fesler P, Dorfmüller P, Sharma S, Karlocai K, Skoro-Sajer N, Jakowitsch J, Moser B, Taghavi S, Klepetko W, Lang IM. (2020); “Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: Hemodynamic Phenotyping and Histomorphometric Assessment. “Circulation. 2020 Feb 4;141(5):376-386. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1) ; Peripheral Vascular disease (Q1).

Ghaleh B, Thireau J, Cazorla O, Soleti R, Scheuermann V, Bizé A, Sambin L, Roubille F, Andriantsitohaina R, Martinez M-C, Lacampagne A (2020). ” Cardioprotective effect of sonic hedgehog ligand in pig models of ischemia reperfusion. ”  Theranostics 2020; 10(9): 4006-4016.  (IF=11,56).  Medicine, Research and Experimental (Q1).

Goulabchand R, Hafidi A, Van de Perre P, Millet I, Maria ATJ, Morel J, Quellec AL, Perrochia H, Guilpain P. (2020). “Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players. “  J Clin Med. 2020 Mar 30;9(4):958. (IF=4,24). Medicine, General and Internal (Q1).

Hamm CW, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Bergland J, Piot C, Roubille F, Schult I, Allocco DJ, Nef H. (2020). “Drug-coated Balloons for the Treatment of Coronary In-stent Restenosis: A Multicentre, Randomised Controlled Clinical Study. “ EuroIntervention. 2020 Jul 17;16(4):e328-e334. (IF=6,53). Cardiac and cCardiovascular Systems (Q2).

Huet F, Dupuy AM, Cristol JP, Roubille F. (2020). “Absolute Change in High Sensitivity Cardiac Troponin I for Three Hours is Useful for Diagnosing Acute Myocardial Infarction in the Emergency Department: How to Get to Best Benefit From HS-Troponins in Clinical Practice?  “ Ann Lab Med. 2020 Nov;40(6):488-489. (IF=3,46). Medical Laboratory Technology (Q2).

Huet F, Prieur C, Schurtz G, Gerbaud E, Manzo-Silberman S, Vanzetto G, Elbaz M, Tea V, Mercier G, Lattuca B, Duflos C, Roubille F. (2020). “Acute cardiovascular diseases may be less likely to be considered because of the COVID-19 pandemic-our duty is first to alert, then to analyse more deeply: Response to a letter entitled “Severity of cardiovascular diseases during the COVID-19 pandemic” from T. Imamura.  “ Arch Cardiovasc Dis. Jun-Jul 2020;113(6-7):486-487. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).

Huet F, Fauconnier J, Legall M, Sicard P, Lozza C, Lacampagne A, Roubille F. (2020). “Low-dose colchicine prevents sympathetic denervation after myocardial ischemia-reperfusion: a new potential protective mechanism.  “ Future Sci OA. 2020 Nov 23;7(2):FSO656. (IF=2,18). Biotechnology (Q3) ; Medicine (Miscellaneous) (Q3).

Huet F, Nicoleau J, Dupuy AM, Curinier C, Breuker C, Castet-Nicolas A, Lotierzo M, Kalmanovich E, Zekowski L, Akodad M, Adda J, Agullo A, Leclercq F, Pasquié JL, Battistella P, Roubille C, Fesler P, Mercier G, Bourel G, Cristol JP, Roubille F. (2020).”STADE-HF (sST2 As a help for management of HF): a pilot study ” ESC Heart Fail 2020 Apr;7(2):774-778 (IF=4,41). Cardiac and Cardiovascular Systems (Q2).

Huet F, Prieur C, Schurtz G, Gerbaud E, Manzo-Silberman S, Vanzetto G, Elbaz M, Tea V, Mercier G, Lattuca B, Duflos C, Roubille F.  (2020). “One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic.  “ Arch Cardiovasc Dis. 2020 May;113(5):303-307. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).

Ichkova A, Rodriguez-Grande B, Zub E, Saudi A, Fournier ML, Aussudre J, Sicard P, Obenaus A, Marchi N, Badaut J. (2020). “Early cerebrovascular and long-term neurological modifications ensue following juvenile mild traumatic brain injury in male mice. “ Neurobiol Dis. 2020 Jul;141:104952. (IF=6,00). Neurosciences (Q1).

Jelinkova S, Vilotic A, Pribyl J, Aimond F, Salykin A, Acimovic I, Pesl M, Caluori G, Klimovic S, Urban T, Dobrovolna H, Soska V, Skladal P, Lacampagne A, Dvorak P, Meli AC, Rotrekl V. (2020).”DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology.  .” Front Bioeng Biotechnol. 2020 Jun 19;8:535. (IF=5,89). Multidisciplinary Sciences (Q2).

Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F, Zemour G, Delarche N, Harbaoui B, Schampaert E, Kouz S, Cayla G, Roubille F, Boueri Z, Mansour S, Marcaggi X, Tardif JC, McGillion M, Tanguay JF, Brophy J, Yu CW, Berry C, Carrick D, Høfsten DE, Engstrøm T, Kober L, Kelbæk H, Belle L. (2020). ” Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial.  ” Can J Cardiol. 2020 Nov;36(11):1805-1814. (IF=5,22).  Cardiac and Cardiovascular Systems (Q1).

Kalmanovich E, Roubille F, Castet-Nicolas A. (2020). “Response to ‘Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial’. “ Eur J Heart Fail. 2020 Mar;22(3):565.  (IF=15,53). Cardiac and Cardiovascular Systems (Q1).

Khoury G, Morel J, Combe B, Lukas C  (2020). “Occurrence of anterior uveitis in patients with spondyloarthritis treated with tumor necrosis factor inhibitors: comparing the soluble receptor to monoclonal antibodies in a large observational cohort.  “ Arthritis Res Ther. 2020 Apr 26;22(1):94. (IF=4,10). Rheumatology (Q1)

Kollen L, Werner O, Gavotto A (2020) « Uncommon Cause of Chest Pain in a 9-Year-Old Boy with Crohn’s Disease.  Gastroenterology. 2020 Jun;158(8):2055-2057.. (IF=22,68). Gastroenterology and Hepatology (Q1).

Kucharczak F, Suau M, Strauss O, Ben Bouallègue F, Mariano-Goulart D (2020). ” Brain ¹⁸F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer’s disease diagnosis. ” Ann Nucl Med. 2020 Aug;34(8):565-574.(IF=2,67). Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2)

Kumar ST, Jagannath S, Francois C, Vanderstichele H, Stoops E, Lashuel HA. (2020). “.How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.  “. Neurobiol Dis. 2020 Dec;146:105086. (IF=6,00. Domaine de Recherche: ” Neurosciences ” (48/271, Q1).

Kuster N, Huet F, Dupuy AM, Akodad M, Battistella P, Agullo A, Leclercq F, Kalmanovich E, Meilhac A, Aguilhon S, Cristol JP, Roubille F  (2020), “Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure.  “ ESC Heart Fail. 2020 Jul 10;7(5):2230-2239.(IF=4,41). Cardiac and Cardiovascular Systems (Q2).

Lambert K, Gondeau C,  Briolotti P, Scheuermann V, Daujat-Chavanieu M, Aimond F  (2020). “Biocompatible modified water as a non-pharmaceutical approach to prevent metabolic syndrome features in obesogenic diet-fed mice“ Food and Chemical Toxicology Volume 141, July 2020, 111403. (IF=6,02). Food Science and Technology (Q1) ; Toxicology (Q1).

Larcher R, Pineton de Chambrun M, Garnier F, Rubenstein E, Carr J, Charbit J, Chalard K, Mourad M, Amalric M, Platon L, Brunot V, Amoura Z, Jaber S, Jung B, Luyt CE, Klouche K. (2020). “One-year outcome of critically ill patients with systemic rheumatic disease: a multicenter cohort study.  “ Chest. 2020 Sep;158(3):1017-1026 (IF=9,41). Critical Care Medicine (Q1) ; Respiratory System (Q1).

Lavilledieu D, Abassi H, Mercier G, Guiraud M, Chaffaut GD, Milesi C, Cambonie G, Gavotto A, Jeziorski E, Amedro P. (2020). “Implementation of an organizational infrastructure paediatric plan adapted to bronchiolitis epidemics.  “Journal of Infection and Public Health 2020 Feb;13(2):167-172. (IF=3,72). Public, Environnemental and Occupational Health (Q2) ; Infectious Diseases (Q3).

Leclercq F, Robert P, Akodad M, Macia JC, Gandet T, Delseny D, Chettouh M, Schumtz L, Robert G, Levy G, Targosz F, Maupas E, Roubille F, Marin G, Nagot N, Albat B, Lattuca B, Caylac G (2020). ” Prior Balloon Valvuloplasty Versus Direct Transcatheter Aortic Valve Replacement: Results From the DIRECTAVI Trial ” JACC Cardiovasc Interv 2020. 13 (5), 594-602 (IF=11,19). Cardiac and Cardiovascular Systems (Q1).

Leclercq F, Lonjon C, Marin G, Akodad M, Roubille F, Macia JC, Cornillet L, Gervasoni R, Schmutz L, Ledermann B, Colson P, Cayla G, Lattuca B  (2020). “Post resuscitation electrocardiogram for coronary angiography indication after out-of-hospital cardiac arrest.  “ Int J Cardiol. 2020 Mar 19:S0167-5273(19)36007-3. (IF=4,16). Cardiac and Cardiovascular Systems (Q2).

Letarouilly JG, Sanchez P, Nguyen Y, Sigaux J, Czernichow S, Flipo RM, Sellam J, Daïen C. (2021).”Efficacy of Spice Supplementation in Rheumatoid Arthritis: A Systematic Literature Review.  ” Nutrients. 2020 Dec 11;12(12):3800.  (IF=5,72). Nutrition and Dietetics  (Q1).

Leurent G, Clément Delmas C, Auffret V, Bonnefoy E, Puymirat E, Roubille F, (2020). “The 50-year-old pulmonary artery catheter: the tale of a foretold death?  “ESC Heart Fail. 2020  2020 Jun;7(3):783-785. (IF= 4,41). Cardiac ad Cardiovascular Systems (Q2).

Lotierzo M, Dupuy AM, Kalmanovich E, Roubille F, Cristol JP. (2020). “sST2 as a value-added biomarker in heart failure. “ Clin Chim Acta.  2020 Feb;501:120-130 (IF=3,79). Medical Laboratory Technology (Q2).

Maïmoun L, Garnero P, Mura T, Nocca D, Lefebvre P, Philibert P, Seneque M, Gaspari L, Vauchot F, Courtet P, Sultan A, Piketty ML, Sultan C, Renard E, Guillaume S, Mariano-Goulart D. (2020). ”Specific effects of anorexia nervosa and obesity on bone mineral density and bone turnover in young women. ” J Clin Endocrinol Metab. 2020 Apr 1;105(4).  (IF=5,80). Endocrinology and Metabolism (Q1).

Maïmoun L, Mura T, Avignon A, Mariano-Goulart D, Sultan A.  (2020). ”Body Composition in Individuals with Obesity According to Age and Sex: A Cross-Sectional Study.  ”J Clin Med. 2020 Apr 21;9(4):E1188.(IF=4,24). Medicine, General and Internal (Q1).

Maïmoun L, Mura T, Attalin V, Dupuy AM, Cristol JP, Avignon A, Mariano-Goulart D, Sultan A. (2020). “ Modification of Muscle-Related Hormones in Women with Obesity: Potential Impact on Bone Metabolism.  “. J Clin Med. 2020 Apr 17;9(4):E1150. (IF=4,24). Medicine, General and Internal (Q1).

Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. (2020).”Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. ” Lancet Haematol. 2020 Jan;7(1):e18-e27 (IF=18,96). Hematology (Q1).

Margarido AS, Le Guen L, Falco A, Faure S, Chauvet N, de Santa Barbara P. (2020).  “PROX1 is a specific and dynamic marker of sacral neural crest cells in the chicken intestine. “ J Comp Neurol.  2020 Apr 1;528(5):879-889.  (IF=3,21). Zoology (Q1) ; Neurosciences (Q2). 

Maury P, Thambo JB, Maltret A, Combes N, Hascoet S, Derval N, Ladouceur M, Acar P, Amedro P, Anselme F, Bajolle F, Basquin A, Belli E, Bordachar P, Duthoit G, Di Filippo S, Fauchier L, Gandjbakhch E, Gras D, Gronier C, Karsenty C, Klug D, Koutbi L, Lacotte J, Laurent G, Laux D, Mansourati J, Marijon E, Ovaert C, Sacher F, Sadoul N, Taieb J, Waldmann V, Warinfresse K, Defaye P, Piot O, Boveda S; Working Group of Pacing, Electrophysiology of the French Society of Cardiology, the Affiliate Group of Paediatric, Adult Congenital Cardiology of the French Society of Cardiology (2020). “Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease.  “ Arch Cardiovasc Dis. Aug-Sep 2020;113(8-9):492-502. (IF=2,34). Cardiac ad Cardiovascular Systems (Q3).

Meli AC. (2020). ”Genome protection on the move.  ” Cardiovasc Res. 2020 Aug 1;116(10):e109-e111. (IF=10,79). Cardiac and Cardiovascular Systems (Q1).

Meli AC, Kranias EG.  (2020). “Scientists on the Spot: calcium dynamics in heart function.  “Cardiovasc Res. 2020 Jun 1;116(7):e73-e74. (IF=10,79). Cardiac and Cardiovascular Systems (Q1).

Meli AC. (2020). “When immune cells are coached by intestinal microbiota. “ Cardiovasc Res. 2020 Feb 1;116(2):e21-e22. ((IF=10,79). Cardiac and Cardiovascular Systems (Q1)

Meli AC, de Tombe P. (2019). “Scientists on the spot: Myocardium and myofilaments. “ Cardiovasc Res. 2020 Jul 1;116(8):e96-e97 (IF=10,79)  Cardiac and Cardiovascular Systems (Q1).

Meli AC, Seidman CE. (2020). “Scientists on the Spot: Putting a halt to hypertrophic cardiomyopathy. “ Cardiovasc Res.  2020 Mar 1;116(3):e42-e43. (IF=10,79). Cardiac and Cardiovascular Systems (Q1).

Mercier G, Arquizan C, Roubille F.  (2020). ” Understanding the effects of COVID-19 on health care and systems.  ” Lancet Public Health. 2020 Oct;5(10):e524. (IF=21,65). Envinronmental and Occupationnal Health (Q1).

Meszaros M, Meunier L, Morquin D, Klouche K, Fesler P, Malezieux E, Makinson A, le Moing V, Reynes J, Pageaux GP. (2020). “Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?  “ Liver Int. 2020 Aug;40(8):1860-1864.. (IF=5,54). Gastroenterology and Hepatolog (Q1).

Moreau J, Lavastre K, Romieu H, Charbonnier F, Guillaumont S, Bredy C, Abassi H, Werner O, De La Villeon G, Requirand A, Auer A, Matecki S, Karsenty C, Guitarte A, Hadeed K, Dulac Y, Soulette N, Acar P, Bajolle F, Bonnet D, Negre-Pages L, Mura T, Mounier M, Seguela PE, Thomas J, Iriart X, Thambo JB, Amedro P. (2020).  “Impact of Sophrology on cardiopulmonary fitness in teenagers and young adults with a congenital heart disease: the SOPHROCARE study rationale, design and methods “IJC Heart & Vasculature, Volume 27, April 2020, 100489. (IF=4,16). Cardiology and Cardiovascular Medicine (Q3).

Morel J, Locci M, Banal F, Combe B, Cormier G, Dougados M, Flipo RM, Marcelli C, Pham T, Rist S, Solau Gervais E, Sibilia J, Lukas C  (2020). “Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.  “ Clin Exp Rheumatol. 2020 May-Jun;38(3):405-410. (IF=4,47). Rheumatology (Q2)

Moreira Souza AC, Grabe-Guimaraes A, Cruz JDS, Santos-Miranda A, Farah C, Teixeira Oliveira L, Lucas A, Aimond F, Sicard P, Mosqueira VCF, Richard S. (2020). “ARTEMETHER TOXICITY MECHANISMS ON SINGLE CARDIOMYOCYTES AND PROTECTIVE EFFECT OF NANOENCAPSULATION. “ Br J Pharmacol. 2020 Jul 1;177(19):4448-4463 (IF=8,74) Pharmacology and Pharmacy (Q1).

Mouterde G, Gamon E, Rincheval N, Lukas C, Seror R, Berenbaum F, Dupuy AM, Daien C, Daurès JP, Combe B. (2020). .Association Between Vitamin D Deficiency and Disease Activity, Disability, and Radiographic Progression in Early Rheumatoid Arthritis: The ESPOIR Cohort.  J Rheumatol. 2020 Nov 1;47(11):1624-1628. (IF=4,67). Rheumatology (Q2)

Najm A, Alunno A, Sivera F, Ramiro S, Haines C; Working Group on Training in Rheumatology across Europe  (avec Daien C) . (2020). “Strategies for the assessment of competences during rheumatology training across Europe: results of a qualitative study.  “RMD Open. 2020 Jul;6(2):e001183. (IF=5,12). Immunology (Q1), Immunology and Allergy (Q1), Rheumatology (Q1)

Nguyen TN, Dubreucq E, Perrier V, Tran QH, Charpentier C, Charnay C, Terki F, Jay-Allemand C, Bidel LPR  (2020). “Interactions between trans-resveratrol and CpLIP2 lipase/acyltransferase: Evidenced by fluorescence and in silico.  “ Food Chem. 2020 Jul 15;318:126482. (IF=7,51). Chemistry Applied (Q1) ; Food Science and Technology (Q1) ; Nutrition and Dietetics (Q1).

Partouche L, Goulabchand R, Maria ATJ, Rivière S, Jorgensen C, Rigau V, Bourgier C, Bessis D, Le Quellec A, Quere I, Morel J, Guilpain P  (2020). “Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature.  “ J Clin Med. 2020 Mar 20;9(3):853. (IF=4,24). Medicine, General and Internal (Q1).

Pineton de Chambrun M, Larcher R, Pène F, Argaud L, Mayaux J, Jamme M, Coudroy R, Mathian A, Gibelin A, Azoulay E, Tandjaoui-Lambiotte Y, Dargent A, Beloncle FM, Raphalen JH, Couteau-Chardon A, de Prost N, Devaquet J, Contou D, Gaugain S, Trouiller P, Grangé S, Ledochowski S, Lemarie J, Faguer S, Degos V, Luyt CE, Combes A, Amoura Z. (2020). ”In-Hospital Mortality-Associated Factors of Thrombotic Antiphospholipid Syndrome Patients Requiring Intensive Care Unit Admission. ” Chest. 2020 May;157(5):1158-1166.. (IF=9,41). Critical Care Medicine (Q1) ; Respiratory System (Q1).

Roncalli J, Roubille F, Lamblin N, Girerd N, Mouquet F, Chapet N, Roubille C, Berthelot E, Galois K, Battistella P, Jondeau G, Tartiere JM, Aguilhon S, Gueffet JP, Salvat M, Damy T, Galinier M; Heart Failure Group of the French Society of Cardiology (2021). “Coronavirus disease vaccination in heart failure: No time to waste.  “  Arch Cardiovasc Dis. 2021 May 24:S1875-2136(21)00088-7 (IF=2,34). Cardiac ad Cardiovascular Systems (Q2).

Roubille C, Henriquez S, Mercuzot C, Duflos C, Dunogue B, Briot K, Guillevin L, Terrier B, Fesler P. (2021). “ Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides. “   J Clin Med. 2021 May 25;10(11):2299. (IF=4;24). Medicine, General and Internal (Q1).

Roubille F, Tardif JC  (2020). ”Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.  ” Circulation. 2020 Nov 17;142(20):1901-1904. (IF=29,69). Cardiac and Cardiovascular Systemss (Q1); Peripheral Vascular disease (Q1).

Roubille F,  Huet F,  Duflos C , (2020). “Total Burden of Events: A New Standard Stressing the Positive Impact of Inflammation Modulation.  “ JACC, 2020 Oct 6;76(14):1671-1673. (IF=24,09). Cardiac and Cardiovascular Systems (Q1).

Ryckebusch F, Sauvion N, Granier M, Roumagnac P, Peterschmitt M..(2020). “Alfalfa leaf curl virus is transmitted by Aphis craccivora in a highly specific circulative manner. “ Virology. 2020 Jul;546:98-108. (IF=3,62). Virology (Q3).

Sánchez-Huertas C, Bonhomme M, Falco A, Fagotto-Kaufmann C, van Haren J, Jeanneteau F, Galjart N, Debant A, Boudeau J.  (2020). The +TIP Navigator-1 is an actin-microtubule crosslinker that regulates axonal growth cone motility.  J Cell Biol. 2020 Sep 7;219(9): e201905199. (IF=10,54). Cell Biology (Q1).

Sanges S, Farhat MM, Assaraf M, Galland J, Rivière E, Roubille C, Lambert M, Yelnik C, Maillard H, Sobanski V, Lefèvre G, Launay D, Morell-Dubois S, Hachulla E  (2020). “Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis.  “. Orphanet J Rare Dis. 2020 Jun 23;15(1):159. (IF=4,12). Medicine, Research and Experimental (Q2);  Genetics and Heradity (Q2).

Santin Y, Fazal L, Sainte-Marie Y, Sicard P, Maggiorani D, Tortosa F, Yücel YY, Teyssedre L, Rouquette J, Marcellin M, Vindis C, Shih JC, Lairez O, Burlet-Schiltz O, Parini A, Lezoualc’h F, Mialet-Perez J (2020). “Mitochondrial 4-HNE derived from MAO-A promotes mitoCa²⁺ overload in chronic postischemic cardiac remodeling. “  Cell Death Differ. 2020 Jun;27(6):1907-1923. (IF=15,83). Biochemistry and Molecular Biology (Q1) ; Cell Biology (Q1).

Silvain J, Lattuca B, Beygui F, Rangé G, Motovska Z, Dillinger JG, Boueri Z, Brunel P, Lhermusier T, Pouillot C, Larrieu-Ardilouze E, Boccara F, Labeque JN, Guedeney P, El Kasty M, Laredo M, Dumaine R, Ducrocq G, Collet JP, Cayla G, Blanchart K, Kala P, Vicaut E, Montalescot G; ALPHEUS investigators (avec Roubille F) (2020). ”Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.  ” Lancet. 2020 Nov 28;396(10264):1737-1744. (IF=79,32). Medicine, General and Internal (Q1).

Sleiman Y, Souidi M, Kumar R, Yang E, Jaffré F, Zhou T, Bernardin A, Reiken S, Cazorla O, Kajava AV, Moreau A, Pasquié JL, Marks AR, Lerman BB, Chen S, Cheung JW, Evans T, Lacampagne A, Meli AC. (2020). “Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes.  “EBioMedicine. 2020 Oct;60:103024. (IF= 8,14). Medicine Research and Experimental (Q1).

Souidi M, Amédro P, Meyer P, Desprat R, Lemaître JM, Rivier F, Lacampagne A, Meli AC (2020). ” Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). ” Stem Cell Research, 2020 Nov 19;49:102094. (IF=2,02).Biotecnology and Applied Microbiology (Q1) ; Cell and Time engenneering (Q2) ; Cell Biology (Q2).

Tartiere JM, Solal AC, Roubille F, Girerd N, Cautela  (2020).”Response to the letter “All rise! Orthostatic Hypotension in Heart Failure”. ” Eur J Heart Fail. 2020 Sep;22(9):1742. (IF=15,53). Cardiac and Cardiovascular Systems (Q1).

Thom K, Lensing AWA, Nurmeev I, Bajolle F, Bonnet D, Kenet G, Massicotte MP, Karakas Z, Palumbo JS, Saracco P, Amedro P, Chain J, Chan AK, Ikeyama T, Lam JCM, Gauger C, Pap ÁF, Majumder M, Kubitza D, Smith WT, Berkowitz SD, Prins MH, Monagle P, Young G, Male C. (2020). “Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE).  “ Blood Adv. 2020 Oct 13;4(19):4632-4639. (IF= 6,69). Hematology (Q1).

Trusson R, Brunot V, Larcher R, Platon L, Besnard N, Moranne O, Barbar S, Serre JE, Klouche K. (2020). “Short- and Long-Term Outcome of Chronic Dialyzed Patients Admitted to the ICU and Assessment of Prognosis Factors: Results of a 6-Year Cohort Study.  “Crit Care Med. 2020 Aug;48(8):e666-e674. (IF=7,60). Critical Care Medicine (Q1).

Urbino C, Regragui ZF, Granier M, Peterschmitt M. (2020). “Fitness advantage of inter-species TYLCV recombinants induced by beneficial intra-genomic interactions rather than by specific mutations. “ Virology. 2020 Mar;542:20-27. (IF=3,62). Virology (Q3).

Varga B, Meli AC, Radoslavova S, Panel M,  Lacampagne A,Gergely C,  Cazorla O, Cloitre T. (2020)“ Internal structure and remodeling in dystrophin-deficient cardiomyocytes using second harmonic generation. “.Nanomedicine, Nanotechnology, Biology and Medicine, 2020 Nov;30:102295 (IF=6,46). Nanoscience and Nanotechnology (Q2) ; Medicine, Research and Experimental (Q1).

Verelst J, Geukens N, Eddarkaoui S, Vliegen D, De Smidt E, Rosseels J, Franssens V, Molenberghs S, Francois C, Stoops E, Bjerke M, Engelborghs S, Laghmouchi M, Carmans S, Buée L, Vanmechelen E, Winderickx J, Thomas D (2020). “. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms.  “. Front Mol Biosci. 2020 Mar 31;7:48. (IF=5,25). Biochemistry and Molecular Biology (Q2)

Villard O, Morquin D, Molinari N, Raingeard I, Nagot N, Cristol JP, Jung B, Roubille C, Foulongne V, Fesler P, Lamure S, TaourelP, Konate A, Jacques Maria AT , Makinson A, Bertchansky A, Larcher R, Klouche K, Le Moing V, Renard E and Guilpain P (2020). ”The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study.  ” Journal of Clinical Medicine, 2020 Jul 21;9(7):E2315. (IF=4,24). Medicine, General and Internal (Q1).

Werner O, Ovaert C, Amedro P. (2020). “Acquired systemic-to-pulmonary shunts in a 6-month-old child: case report and review of the literature. “ Cardiol Young. 2020 Feb 10:1-4. (IF=1,09). Cardiac and Cardiovascular Systems (Q4) ; Pediatry (Q4).

Young G, Lensing AWA, Monagle P, Male C, Thelen K, Willmann S, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bajolle F, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Beyer-Westendorf J, Martinelli I, Patricia Massicotte M, Smith WT, Berkowitz SD, Schmidt S, Price V, Prins MH, Kubitza D; EINSTEIN-Jr. Phase 3 Investigators (2020). ”Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation.  ” J Thromb Haemost. 2020 Jul;18(7):1672-1685. (IF=5,82).

Zieleskiewicz L, Claret PG, Muller L, de La Coussaye JE, Lefrant JY, Schuster I, Roger C, Bobbia X. (2020). “Global longitudinal strain changes during hemorrhagic shock: An experimental study. “  Turk J Emerg Med. 2020 Jul 18;20(3):97-104. (IF=1,39).    Critical Care and Intensive Care Medicine (Q2); Emergency Medicine (Q2).